Indian Journal of Cardiovascular and General Surgery

The Indian Journal of Cardiovascular and General Surgery serves as a vital platform for the dissemination of cutting-edge research, innovative surgical techniques, and comprehensive clinical insights within the diverse fields of cardiovascular and general surgery. As a peer-reviewed publication, it is dedicated to advancing the scientific knowledge base and practical application of surgical principles, reflecting the unique challenges and advancements pertinent to the Indian subcontinent and beyond. The journal welcomes original research, review articles, case reports, and technical notes that contribute significantly to the understanding and treatment of surgical conditions affecting the heart, blood vessels, and various general surgical domains. Through its rigorous editorial process, the journal aims to foster academic discourse, facilitate knowledge exchange, and ultimately contribute to improved patient outcomes in these critical surgical specialties.

IJCGS Medical Science is a peer-reviewed, open-access journal that exclusively publishes manuscripts focusing on various branches of including Cardiology, Heart Related, Blood Vessels, Coronary Artery & General Surgery.

Copy of Green Colorful Gradient Daily Journal Cover.png

Submit Manuscript: editor@ijcgs.com

Recent View Article

Rescuing the "Forgotten Valve": Clinical Outcomes and Procedural Innovations in Transcatheter Tricuspid Edge-to-Edge Repair

Review Paper | 2026 | Volume 2 | Issue 1 | Page 15-24 1. Dr. Ibrahim Kureshy, Lecturer, Cardiology, DMCH-UAE 2. Dr. Rabia Fatima, Lecturer, Cardiology, DMCH-UAE Abstract Background: For decades, tricuspid regurgitation (TR) was relegated to the status of the "forgotten valve," often managed conservatively until the onset of irreversible right heart failure. However, the 2024–2026 clinical landscape has been redefined by the success of Transcatheter Tricuspid Edge-to-Edge Repa

2026, Volume-2, Issue-1

The Twilight of Aspirin: A Meta-Analysis of P2Y12 Inhibitor Monotherapy vs. Dual Antiplatelet Therapy (DAPT) Following Third-Generation Drug-Eluting Stent Implantation.

Original Research | 2026 | Volume 2 | Issue 1 | Page 01-14 Dr. Ibrahim Kureshy, Lecturer, Cardiology, DMCH-UAE Abstract For decades, dual antiplatelet therapy (DAPT)—combining aspirin with a P2Y_{12} inhibitor—has been the gold standard for preventing thrombotic complications following percutaneous coronary intervention (PCI). However, the advent of third-generation drug-eluting stents (DES) with thinner struts and biocompatible polymers has significantly reduced stent thromb

2026, Volume-2, Issue-1

The "24/7" Cardiologist: Integration of Continuous Wearable Sensor Data into AI-Driven Heart Failure Predictive Models.

Original Research | 2026 | Volume 2 | Issue 1 | Page 25-33 Dr. Amin Sekha Hassain, Professor, Cardiology, Dubai Medical College, UAE Abstract The management of Chronic Heart Failure (CHF) is currently transitioning from intermittent, clinic-based snapshots to a model of Continuous Physiological Surveillance . In the 2024–2026 digital health landscape, the proliferation of consumer-grade and medical-grade wearables (smartwatches, rings, and patches) has created a vast reservoi

2026, Volume-2, Issue-1

Intravascular Ultrasound (IVUS) versus Optical Coherence Tomography (OCT) in the Era of High-Potency Statins: A Comparative Analysis of Plaque Morphological Assessment.

Original Research | 2025 | Volume 1 | Issue 1 | Page 70-79 Dr. Ibrahim Kureshy, Lecturer, Cardiology, DMCH-UAE Dr. Rabia Fatima, Lecturer, Cardiology, DMCH-UAE Abstract The clinical management of coronary artery disease has evolved from a focus on luminal diameter to a deep molecular understanding of Plaque Vulnerability . In the 2024–2026 era, the widespread use of high-potency statins, PCSK9 inhibitors, and Inclisiran has fundamentally altered the "Biological Landscape" of

2025, Volume-1, Issue-1

Navigating the "Prohibitive Risk" Frontier: A Contemporary Review of Mechanical Circulatory Support in Complex High-Risk Indicated Patient (CHIP) Interventions.

Original Research | 2025 | Volume 1 | Issue 1 | Page 60-69 Dr. Jambia Khatoon, Assistant Professor, Cardiology, IPGMER, Kolkata Abstract The definition of "revascularization candidates" has undergone a radical expansion, moving into the CHIP (Complex High-Risk Indicated Patient) domain. This population is defined by a "Triple Threat" of complex coronary anatomy (CTO, multivessel disease, severe calcification), severely depressed left ventricular function (LVEF < 35%), and pr

2025, Volume-1, Issue-1

Deep Learning-Enhanced ECG Analysis for the Prediction of Occult Atrial Fibrillation: A Multi-Center Prospective Validation Study

Original Research | 2025 | Volume 1 | Issue 1 | Page 50-59 Dr. Sayama Prasad, Professor, Cardiology, GMC-Asam Dr. Arun Sharma, Professor, Cardiology, GMC-Jalgaow Abstract Background: Atrial Fibrillation (AFib) remains a leading cause of cryptogenic stroke due to its often paroxysmal and asymptomatic ("occult") nature. Traditional screening relies on symptomatic presentation or prolonged Holter monitoring, which often fails to capture intermittent episodes. This study evaluat

2025, Volume-1, Issue-1

The Convergence of Robotics and Artificial Intelligence in Percutaneous Coronary Intervention: A 2026 Vision of Autonomous Revascularization

Review Paper | 2025 | Volume 1 | Issue 1 | Page 40-49 Dr. Abhisekh Gangauly, Lecturer, Department of Cardiology, IPGMER, Kolkata Abstract The traditional practice of Percutaneous Coronary Intervention (PCI) is currently undergoing a dual transformation, shifting from manual, tactile-dependent maneuvers to a high-precision, digitalized framework. This review evaluates the clinical and technical convergence of Robotic-Assisted PCI (R-PCI) and Artificial Intelligence (AI) , a s

2025, Volume-1, Issue-1

Future Horizons: Nanotechnology and Gene Therapy

Review Paper | 2025 | Volume 1 | Issue 1 | Page 17-25 Dr. Amrish Singh, Lecturer, Department of Genetics, SNS College, Nawada Abstract As we approach the 2030 threshold, the paradigm of interventional cardiology is shifting from mechanical restoration to biological rejuvenation. The final frontier of "NextGen" cardiology lies in the integration of Nanotechnology and Gene Therapy, moving beyond the macro-scale of stents and valves into the sub-cellular environment. This chapte

2025, Volume-1, Issue-1

Pharmacology in the Era of Intervention

Review Paper | 2026 | Volume 2 | Issue 1 | Page 84-88 Dr. Abhimita Singh, Professor, Cardiology, JMCH, Jalgwao, MP Abstract While mechanical and robotic innovations have redefined the physical landscape of the catheterization lab, the success of these procedures remains inextricably linked to advanced Pharmacotherapy. The "NextGen" era of intervention is not just about the hardware of stents and valves, but the biological management of the blood-surface interface. This chapte

2026, Volume-2, Issue-1

Complex High-Risk Indicated Patient (CHIP) Interventions

Review Paper | 2026 | Volume 2 | Issue 1 | Page 78 - 83 Dr. Amali Singh Tanuja, Assistant Professor, Department of Cardiology, GMC, Sis UP Abstract The clinical landscape of interventional cardiology is increasingly defined by the CHIP (Complex High-Risk Indicated Patient) population—a cohort characterized by complex coronary anatomy, severe hemodynamic compromise, and multiple systemic comorbidities. Historically, these patients were often deemed "inoperable" or "un-treatab

2026, Volume-2, Issue-1